|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2009-3-12
|
|
pubmed:abstractText |
The attenuated, tissue-cultured, third-generation smallpox vaccine LC16m8 was administered to vaccinia-naive infants in Japan during the 1970s without serious adverse events. It is a good candidate for use as part of a prevention plan for bioterrorism.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1538-3598
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
11
|
|
pubmed:volume |
301
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1025-33
|
|
pubmed:meshHeading |
pubmed-meshheading:19278946-Adolescent,
pubmed-meshheading:19278946-Adult,
pubmed-meshheading:19278946-Antibodies, Viral,
pubmed-meshheading:19278946-Humans,
pubmed-meshheading:19278946-Immunity, Active,
pubmed-meshheading:19278946-Immunization, Secondary,
pubmed-meshheading:19278946-Immunization Programs,
pubmed-meshheading:19278946-Japan,
pubmed-meshheading:19278946-Middle Aged,
pubmed-meshheading:19278946-Military Personnel,
pubmed-meshheading:19278946-Neutralization Tests,
pubmed-meshheading:19278946-Smallpox Vaccine,
pubmed-meshheading:19278946-Vaccination,
pubmed-meshheading:19278946-Vaccines, Attenuated,
pubmed-meshheading:19278946-Vaccinia virus,
pubmed-meshheading:19278946-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8.
|
|
pubmed:affiliation |
Bio-preparedness Research Laboratory, Department of Tropical Medicine and Parasitology, School of Medicine, Keio University, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
